U.S. Cancer Biopsy Market size is expected to reach USD 15.98 billion by 2028
U.S. Cancer Biopsy Industry Overview The U.S. cancer biopsy market size was valued at USD 6.96 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.0% from 2021 to 2028. The increasing popularity of image-guided needle biopsies in precision medicine applications and a rise in the adoption of biopsies based on multi-parametric Magnetic Resonance (MR) imaging are the key factors driving the market. Furthermore, the advent of liquid biopsies, rising clinical implementation of biopsies, and advancements in quality and payment pertaining to genetic oncology diseases are expected to propel market growth in the near future. The increasing prevalence of oncology indications and the growing geriatric population is also likely to fuel the market growth. Combined development and the implementation of solid and liquid biopsies in oncology management are driving the market at a lucrative rate. Gather more insights about the market d...